Table 4.

Unadjusted and adjusted multivariable linear regression models of the extent of plaque to left ventricular mass (LVM) and left ventricular mass index (LVMi) based on the 3 LVMi criteria.

	Unadjusted		Model A†		Model B††
	β-estimate (95% CI)	p-value	β-estimate (95% CI)	p-value	β-estimate (95% CI)	p-value
LVM/BSAASE cohort
LVM (per 20 g)	0.28 (0.09, 0.48)	0.004	0.24 (0.01, 0.47)	0.04	0.27 (0.04, 0.50)	0.02
LVM/BSAASE (per 10 g/m2 )	0.40 (0.13, 0.66)	0.003	0.28 (0.03, 0.54)	0.03	0.32 (0.05, 0.58)	0.02
LVM/height2.7 cohort
LVM (per 20 g)	0.28 (0.08, 0.49)	0.007	0.27 (0.03, 0.50)	0.02	0.29 (0.05, 0.53)	0.02
LVM/height2.7 (per 10 g/m2.7)	0.74 (0.15, 1.32)	0.01	0.77 (0.20, 1.35)	0.009	0.80 (0.21, 1.39)	0.008
LVM/BSACT cohort
LVM (per 20 g)	0.24 (0.04, 0.45)	0.02	0.25 (0.004, 0.50)	0.046	0.29 (0.04, 0.55)	0.02
LVM/BSACT (per 10 g/m2)	0.33 (0.04, 0.62)	0.02	0.30 (0.02, 0.59)	0.04	0.34 (0.05, 0.64)	0.02

^†Model A was adjusted for age, gender, race, hypertension, diabetes, hyperlipidemia, history of coronary artery disease, family history of coronary artery disease, history of left ventricular dysfunction, smoking, aspirin, statin, systolic blood pressure, estimated glomerular filtration rate, and left ventricular ejection fraction measured by CT. Body mass index was included only in the LVM model.

^††Model B was adjusted for all covariates in model A with the addition of relative wall thickness as a continuous variable.